The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 181 - 210 of 285 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti
|
Livopan 50 % - 50 % lääkkeelinen kaasu, puristettu, SPC 2022-04-27
|
PL
|
Itsehoito
|
Livostin 0.5 mg-ml nenäsumute, suspensio SPC 2024-09-16
|
PL
|
Itsehoito
|
Livostin 0.5 mg-ml silmätipat, suspensio SPC 2022-10-03
|
|
|
European Medicines Agency's website: Lixiana - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Lixim 70 mg lääkelaastari SPC 2019-08-19
|
|
|
European Medicines Agency's website: Loargys - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Locacorten-Vioform 0.2 mg-ml + 10 mg-ml korvatipat, liuos SPC 2021-04-06
|
|
|
European Medicines Agency's website: Locametz - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Loceryl 5-prosenttinen lääkekynsilakka SPC 2021-09-30
|
PL
|
Resepti
|
Locoid 0.1 prosenttinen emulsiovoide SPC 2024-05-06
|
PL
|
Resepti
|
Locoid 0.1 prosenttinen liuos iholle SPC 2022-02-07
|
PL
|
Resepti
|
Locoid 0.1 prosenttinen voide SPC 2024-05-06
|
PL
|
Resepti
|
Locoid Crelo 0.1 prosenttinen emulsio iholle SPC 2022-06-01
|
PL
|
Resepti
|
Locoid Lipid 0.1 prosenttinen emulsiovoide SPC 2024-05-06
|
PL
|
Resepti
|
Logimax 5 mg - 47,5 mg depottabletti SPC 2022-08-29
|
PL
|
Resepti
|
Logimax Forte 10 mg - 95 mg depottabletti SPC 2022-08-29
|
|
|
European Medicines Agency's website: Lojuxta - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Lokelma - EMA: EPAR PI
Finnish Swedish
|
PL
|
Itsehoito
|
Lomudal 20 mg-ml silmätipat, liuos SPC 2023-09-28
|
PL
|
Itsehoito
|
Lomudal 40 mg-ml silmätipat, liuos, kerta-annospakkaus SPC 2023-09-28
|
PL
|
Resepti
|
Lomustine medac 40 mg kapseli, kova SPC 2024-01-30
|
|
|
European Medicines Agency's website: Lonquex - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Lonsurf - EMA: EPAR PI
Finnish Swedish
|
PL
|
Itsehoito
|
Lopacut 2 mg tabletti, kalvopäällysteinen SPC 2022-04-04
|
PL
|
Resepti
|
Loperamide Grindeks 2 mg kapseli, kova SPC 2023-04-25
|
PL
|
Itsehoito
|
Loperamide Tenshi 2 mg tabletti, kylmäkuivattu SPC 2024-03-16
|
PL
|
Resepti/itsehoito
|
Lopex 2 mg kapseli, kova SPC 2024-08-13
|
PL
|
Resepti
|
Lopinavir-Ritonavir Accord 200 mg-50 mg tabletti, kalvopäällysteinen SPC 2023-01-17
|
|
|
European Medicines Agency's website: Lopinavir/Ritonavir Viatris (ent. Lopinavir/ritonavir Mylan) - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: LOQTORZI - EMA: EPAR PI
Finnish Swedish
|
|